| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| DDAVP, dDAVP | 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin |
| SS | disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-... |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OET | oral endotracheal tube; oral esophageal tube |
| ORS | G)-oral rehydration solution |
|---|---|
| L-NAME | L-arginine and NG-nitro-L-arginine methyl ester |
| BSS | 3)balanced salt solution |
| EBSS | Earl's balanced salt solution |
| ECS | Euro Collins solution |
| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| arginine | <amino acid> An essential amino acid, a major component of proteins and contains the guanido group that has a pKa of greater than 12, so that it carries a permanent positive charge at physiological pH. It becomes an essential amino acid when the body is under stress or is in an injured state. Depressed growth results from lack of dietary arginine. Arginine deficiency syndrome is observed in human babies born with a phosphate synthetase deficiency. Normal growth and development in these infants are achieved by adding arginine to their diet. Arginine deficiency leads to carbamyl phosphate overproduction in the mitochondria due to inadequate ornithine supply. Arginine-deficient diets in males causes decreased sperm counts. Free and bound arginine are found in abundance in human male sperm and arginine has been found to stimulate sperm motility. There are two sources of arginine, arginine in the food chain and free-form arginine from supplements. Food-source arginine is found in abundance in turkey, chicken and other meats. Nonfood-source arginine is called L-arginine and is created through a fermentation process which separates arginine from all other proteins. In the presence of food and other amino acids, L-arginine will act like food-source arginine but when L-arginine is separated from its nutrient boundaries by the removal of all other amino acids, then L-arginine undertakes a different role, becoming capable of crossing the blood-brain barrier and stimulating growth hormone release secreted by the anterior pituitary. Growth hormone serum levels peak during adolescence and begin to drop after age 23. Aging reduces natural growth hormone production, which results in added body fat, reduced muscle tissue, slowed healing, lack of elasticity in the skin and reduced immune function. Human pituitary growth hormone secretion is evidenced in human males, females and children following intravenous administration of 30 grams of arginine (in 30 minutes) in adults and 0.5 grams/kilogram of bodyweight in children. Female response is somewhat higher than male response. Oral administration of L-arginine also results in the release of Human Growth Hormone. Tumour suppression is evidenced in the presence of L-arginine. In the Barbul study, tumours recurred in 100% of the control animals. But in the arginine-supplemented group, only about 60% of the tumours recurred and the animals with tumours survived longer. Supplementation of arginine in the diet inhibits development and increase in size of cancerous tumours, both chemically induced and naturally occurring. Insulin can block growth hormone release, so high serum insulin levels are counterproductive to GH release. Insulin itself is capable of stimulating muscle growth, but it also strongly stimulates fat storage. Muscle growth stimulation from insulin is minuscule compared to muscle growth stimulated by growth hormone. (13 Nov 1997) |
|---|---|
| arginine 2-monooxygenase | <enzyme> Catalyses oxidative decarboxylation or arginine to form gamma-guanidinobutyramide (4-guanidinobutanamide) Registry number: EC 1.13.12.1 Synonym: arginine decarboxyoxidase (26 Jun 1999) |
| arginine amidase | <enzyme> A ureahydrolase that catalyses the hydrolysis of arginine and canavanine to yield l-ornithine and urea. Chemical name: L-Arginine amidinohydrolase Registry number: EC 3.5.3.1 (12 Dec 1998) |
| arginine deiminase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine dihydrolase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine endopeptidase | <enzyme> Cleaves arginine at the carboxyl side in a peptide chain Registry number: EC 3.4.21.- Synonym: arginyl endopeptidase (26 Jun 1999) |
| arginine esterase | <enzyme> Probably refers to an aspect of a proteinase; also index to specific proteinase class Registry number: EC 3.1.- Synonym: me-1,arginine ester hydrolase, me-2, me 1,me 2, arginine esterase a, esterase e-ii, esterase a (26 Jun 1999) |
| arginine glutamate | A compound composed of arginine and glutamic acid, given intravenously to detoxify ammonia; used in the treatment of ammoniaemia resulting from liver dysfunction. (05 Mar 2000) |
| arginine hydrochloride | A form of arginine used for intravenous administration as an adjunct in the treatment of encephalopathies associated with liver diseases and ammoniacal azotemia. (05 Mar 2000) |
| arginine iminohydrolase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine kinase | <enzyme> An enzyme that catalyses the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. Chemical name: ATP:L-arginine N-phosphotransferase Registry number: EC 2.7.3.3 (12 Dec 1998) |
| arginine oxidase | <enzyme> Catalyses the oxidative deamination from arginine to 2-ketoarginine Registry number: EC 1.4.3.- Synonym: arginine dehydrogenase (26 Jun 1999) |
| arginine phosphate | A compound (in particular, a phosphagen) of l-arginine with phosphoric acid containing the phosphoamide bond; a source of energy in the contraction of muscle in invertebrates, corresponding to phosphocreatine in the muscles of vertebrates. Compare: phosphocreatine. Synonym: arginine phosphate. (05 Mar 2000) |
| arginine succinyltransferase | <enzyme> Pseudomonas (burkholderia) cepacia enzyme; forms n(2)-succinylarginine; in pseudomonas aeruginosa enzyme uses either arginine or ornithine as acceptor Registry number: EC 2.3.1.- Synonym: orn-st, ornithine succinyltransferase (26 Jun 1999) |
| arginine-trna ligase | <enzyme> An enzyme that activates arginine with its specific transfer RNA. Chemical name: L-Arginine:tRNA(Arg)ligase (AMP-forming) Registry number: EC 6.1.1.19 (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
아르기닌베이론액 - 새창
|
우전약품교역 |
Arginine HCl | 일반의약품 | 비급여 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|